ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01BB04 | B | Cladribine - 10mg | 9539 | 29218/1 | MAVENCLAD | 10mg | 4 | Tablet | Oral | Food & Drug Corporation FDC | R-Pharm Germany GmbH | Germany | 14,516,623 L.L | 2.44 | E2 | Merck Serono Europe Ltd | UK | 2/1/2023 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01BB04 | B | Cladribine - 10mg | 9538 | 29118/1 | MAVENCLAD | 10mg | 1 | Tablet | Oral | Food & Drug Corporation FDC | R-Pharm Germany GmbH | Germany | 2,974,811 L.L | 2.44 | E2 | Merck Serono Europe Ltd | UK | 2/1/2023 |
L01BB04 | B | Cladribine - 10mg | 9540 | 29318/1 | MAVENCLAD | 10mg | 6 | Tablet | Oral | Food & Drug Corporation FDC | R-Pharm Germany GmbH | Germany | 21,776,733 L.L | 2.44 | E2 | Merck Serono Europe Ltd | UK | 2/1/2023 |
L01BB04 | B | Cladribine - 10mg | 10977 | 15522/1 | MAVENCLAD | 10mg | 1 | Tablet | Oral | Food & Drug Corporation FDC | R-Pharm Germany GmbH | Germany | 2,974,811 L.L | 2.44 | E2 | Merck Europe BV | The Netherlands | 2/1/2023 |